Abstract
Recurrent painful ophthalmoplegic neuropathy (RPON), formerly known as ophthalmoplegic migraine, is a rare condition characterised by recurrent attacks of unilateral headache with ipsilateral ophthalmoplegia. Although classified as a cranial neuralgia, the exact pathophysiology behind RPON is unclear and the clinical presentation often resembles migraine headaches. Here, the authors present the case of a patient with RPON who, after numerous therapeutic failures, received erenumab and experienced significant improvement. This case supports the argument that RPON should be reclassified as a migraine variant, which would enable the use of specific prophylactic medication in patients suffering from this disorder.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
